Security Snapshot

Elanco Animal Health Inc - Common Stock (ELAN) Institutional Ownership

CUSIP: 28414H103

13F Institutional Holders and Ownership History from Q1 2016 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

521

Shares (Excl. Options)

566.85MFull value: 566,847,886 · shares · 30 Jun 2026

Price

$24.61

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
ELAN on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
566,847,886
Latest holder snapshot 5 signals
Total 13F value
$13,947,410,498
Portfolio coverage rank
0.01%
Share change
+21,182,862
Value change
+$523,292,898
Number of holders
521
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
498,377,863
SEC-reported price per share
$22.39
Insider filing price
$22.39
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ELAN - Elanco Animal Health Inc - Common Stock is tracked under CUSIP 28414H103.
  • 521 institutions reported positions in Q2 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 519 to 521 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $13.06BFull value: $13,057,720,262 · USD · 31 Mar 2026
    to
    $13.95BFull value: $13,947,410,498 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 521 institutions filings for Q2 2026.

Open SEC evidence

Security key

28414H103

13F reference period

Q2 2026

13F holders

521

13D/G owners

7

CIK / CUSIP context first

Open Q2 2026 holders ELAN full holder history Elanco Animal Health Inc SEC filings Elanco Animal Health Inc company facts Elanco Animal Health Inc insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
ELAN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 14% -12% $1,573,304,362 -$231,399,478 68,944,100 -13% Dodge & Cox 31 Mar 2026
FMR LLC 10% -20% $1,181,202,753 -$287,108,530 52,196,321 -20% FMR LLC 31 Dec 2025
PRIMECAP MANAGEMENT CO/CA/ 9.2% $1,046,090,616 45,840,956 PRIMECAP MANAGEMENT CO/CA/ 31 Mar 2026
BlackRock, Inc. 8.9% +112% $886,598,367 +$443,042,097 44,021,766 +100% BlackRock, Inc. 30 Sep 2025
T. Rowe Price Investment Management, Inc. 6.4% $635,376,116 31,547,970 T. Rowe Price Investment Management, Inc. 30 Sep 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $625,506,031 26,138,990 Vanguard Capital Management 31 Mar 2026
DIMENSIONAL FUND ADVISORS LP 5.1% +4% $625,519,039 +$21,906,247 25,417,271 +3.6% Dimensional Fund Advisors LP 30 Jun 2026
As of 30 Jun 2026, 521 institutional investors reported holding
566.85MFull value: 566,847,886 · shares · 30 Jun 2026
shares of Elanco Animal Health Inc - Common Stock (ELAN). This represents 114% of the company’s total
498.38MFull value: 498,377,863 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
90%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 14% 67,397,025 -2.2% 0.87% $1,658,640,785
FMR LLC 11% 56,948,819 +12% 0.06% $1,401,510,441
BlackRock, Inc. 9.8% 48,849,973 +2.6% 0.02% $1,202,197,843
PRIMECAP MANAGEMENT CO/CA/ 9.1% 45,445,012 -0.86% 0.66% $1,118,401,745
T. Rowe Price Investment Management, Inc. 5.8% 28,750,719 -17% 0.46% $707,556,000
DIMENSIONAL FUND ADVISORS LP 5.1% 25,417,271 +3.6% 0.11% $625,528,870
VANGUARD PORTFOLIO MANAGEMENT LLC 4.5% 22,672,312 +0.15% 0.03% $557,965,598
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 22,607,532 +1.2% 0.01% $556,371,363
STATE STREET CORP 3.2% 16,063,046 +4.7% 0.01% $395,311,562
Winslow Capital Management, LLC 2.7% 13,511,127 -0.76% 1.1% $332,508,835
Black Creek Investment Management Inc. 2.6% 13,046,420 +24% 18% $321,072,396
GEODE CAPITAL MANAGEMENT, LLC 2.3% 11,302,057 +0.98% 0.01% $278,202,108
UBS Group AG 2% 9,910,822 +16% 0.04% $243,905,329
CITADEL ADVISORS LLC 1.9% 9,668,611 +120% 0.14% $237,944,517
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.7% 8,355,772 +34% 0.16% $205,635,549
MORGAN STANLEY 1.6% 7,854,361 +22% 0.01% $193,295,854
FULLER & THALER ASSET MANAGEMENT, INC. 1.3% 6,240,240 +3.7% 0.42% $153,572,314
Invesco Ltd. 1.1% 5,306,326 -35% 0.01% $130,588,683
SEI INVESTMENTS CO 1.1% 5,284,773 -6.5% 0.11% $130,058,416
JENNISON ASSOCIATES LLC 0.9% 4,508,395 +44% 0.07% $110,951,603
MARSHALL WACE, LLP 0.89% 4,432,350 +221% 0.09% $109,080,132
NORTHERN TRUST CORP 0.85% 4,256,056 +1.6% 0.01% $104,741,538
JUPITER ASSET MANAGEMENT LTD 0.85% 4,219,279 +36% 0.52% $103,836,456
BANK OF AMERICA CORP /DE/ 0.78% 3,909,871 +16% 0.01% $96,221,913
Clearbridge Investments, LLC 0.75% 3,716,181 -19% 0.08% $91,455,213

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
35
Headline period
Q2 2026
Rows shown
1-25 of 35
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 12,972,780 $290,134,792 +$25,659,145 $22.39 133
2026 Q2 566,847,886 $13,947,410,498 +$523,292,898 $24.61 521
2026 Q1 545,874,756 $13,057,720,262 +$178,494,783 $23.93 519
2025 Q4 539,069,203 $12,199,782,213 -$765,326,894 $22.63 482
2025 Q3 570,844,069 $11,496,298,982 +$680,262,488 $20.14 406
2025 Q2 538,352,937 $7,687,668,693 +$655,647,979 $14.28 362
2025 Q1 494,022,445 $5,187,492,485 +$2,004,620 $10.50 359
2024 Q4 489,345,019 $5,925,862,528 +$26,438,350 $12.11 387
2024 Q3 481,862,274 $7,076,192,785 -$28,345,131 $14.69 384
2024 Q2 482,171,600 $6,957,441,182 +$6,686,922 $14.43 396
2024 Q1 480,177,163 $7,816,997,297 +$26,389,803 $16.28 370
2023 Q4 479,962,841 $7,151,250,374 +$21,579,978 $14.90 349
2023 Q3 481,442,000 $5,409,895,330 +$102,163,765 $11.24 344
2023 Q2 473,375,354 $4,760,610,377 -$67,531,728 $10.06 345
2023 Q1 479,522,703 $4,495,944,050 -$110,942,259 $9.40 384
2022 Q4 481,681,648 $5,908,155,843 +$232,156,887 $12.22 398
2022 Q3 463,043,345 $5,755,609,685 -$196,296,127 $12.41 398
2022 Q2 470,431,046 $9,236,728,928 -$88,523,747 $19.63 421
2022 Q1 473,375,688 $12,362,622,405 -$47,241,309 $26.09 454
2021 Q4 475,123,500 $13,465,426,403 +$218,382,206 $28.38 461
2021 Q3 467,401,656 $14,907,014,269 -$71,757,204 $31.89 435
2021 Q2 468,283,929 $16,250,367,215 +$128,764,524 $34.69 464
2021 Q1 467,015,636 $13,752,652,796 +$242,000,095 $29.45 433
2020 Q4 458,146,787 $14,050,001,284 +$1,375,218,703 $30.67 424
2020 Q3 413,516,389 $11,539,620,540 +$535,290,448 $27.93 348
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .